Skip to main content
Top
Published in: Obesity Surgery 5/2010

01-05-2010 | Clinical Report

Comparison of Early and Late Changes in Immunoglobulins and Acute Phase Reactants after Laparoscopic Adjustable Gastric Banding in Patients with Morbid Obesity

Authors: İbrahim Sakçak, Mehmet Fatih Avşar, Enver Okan Hamamcı, Settar Bostanoğlu, Muhittin Sonışık, Akın Bostanoğlu, Nihal Zekiye Erdem, Erdal Coşgun

Published in: Obesity Surgery | Issue 5/2010

Login to get access

Abstract

Background

There are differences in the levels of inflammation mediators, lipids, and formed elements of the blood in morbidly obese patients compared with individuals of normal weight. In the current study, the change in these parameters was determined in patients who achieved weight loss by undergoing laparoscopic adjustable gastric banding (LAGB) by comparing preoperative, and early (3 months) and late (12 months) postoperative values.

Methods

The body mass index (BMI), weight, blood pressure, and waist circumference of 72 patients treated by LAGB procedures between September 2006 and February 2009 were measured and recorded. Pre- and postoperative 3- and 12-month C-reactive protein (CRP), immunoglobulin (Ig) G, IgA, IgM, fibrinogen (Fbg), complement components C3 and C4, total cholesterol, triglycerides, low-density lipoprotein-C and high-density lipoprotein-C levels, and leukocyte, neutrophil, lymphocyte, and platelet counts were also measured. Results were presented as mean ± SD. The preoperative values were compared with the 3- and 12-month values. A p value < 0.05 was considered statistically significant.

Results

BMI, weight, blood pressure, and waist circumference measurements were reduced at 3 and 12 months postoperatively compared with preoperative values (p < 0.05). Among the inflammatory mediators, IgG, IgM, and Fbg were reduced to near-normal values, beginning in the early postoperative period (p < 0.05). There was no significant reduction parallel to weight loss with respect to CRP, C3, C4, and IgA values at 3 months postoperatively (p > 0.05). However, the 12-month values of these parameters were significantly reduced (p < 0.05).

Conclusions

Morbid obesity leads to significant changes in the levels of inflammation mediators. While there is a significant reduction in some of these mediators accompanying slight weight loss in the early period following an LAGB procedure, significant changes occur in other mediators in the late period when there is a larger amount of weight loss.
Literature
1.
go back to reference Lew EA, Garfinkel L. Variations in mortality by weight among 750, 000 men and women. J Chronic Dis. 1979;32:563–76.CrossRefPubMed Lew EA, Garfinkel L. Variations in mortality by weight among 750, 000 men and women. J Chronic Dis. 1979;32:563–76.CrossRefPubMed
2.
go back to reference National Institutes of Health. National Institutes of Health Consensus Development panel on the Health Implications of Obesity. National Institutes of Health Consensus development conference statement. Ann Intern Med. 1985;103:1072–7. National Institutes of Health. National Institutes of Health Consensus Development panel on the Health Implications of Obesity. National Institutes of Health Consensus development conference statement. Ann Intern Med. 1985;103:1072–7.
3.
go back to reference Krishnan EC, Trost L, Aarons S, et al. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982;33:89–97.CrossRefPubMed Krishnan EC, Trost L, Aarons S, et al. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982;33:89–97.CrossRefPubMed
4.
go back to reference Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589–600.CrossRefPubMed Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589–600.CrossRefPubMed
5.
go back to reference Brownell KD, Greenwood MR, Stellar E, et al. The effects of repeated cycles of weight loss and regain in rats. Physiol Behav. 1986;38:459–64.CrossRefPubMed Brownell KD, Greenwood MR, Stellar E, et al. The effects of repeated cycles of weight loss and regain in rats. Physiol Behav. 1986;38:459–64.CrossRefPubMed
6.
go back to reference Holt RI. International Diabetes Federation re-defines the metabolic syndrome. Diabetes Obes Metab. 2005;7:618–20.CrossRefPubMed Holt RI. International Diabetes Federation re-defines the metabolic syndrome. Diabetes Obes Metab. 2005;7:618–20.CrossRefPubMed
7.
go back to reference Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRefPubMed Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.CrossRefPubMed
8.
go back to reference Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971–7.CrossRefPubMed Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971–7.CrossRefPubMed
9.
go back to reference Schuchert VD, Billiar TR. Inflammation. In: Greenfield LJ, editor. Surgery Scientific principals and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 134–78. Schuchert VD, Billiar TR. Inflammation. In: Greenfield LJ, editor. Surgery Scientific principals and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 134–78.
10.
go back to reference Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145–58.CrossRefPubMed Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145–58.CrossRefPubMed
11.
go back to reference Weinhold B, Rüther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J. 1997;327:425–9.PubMed Weinhold B, Rüther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J. 1997;327:425–9.PubMed
12.
go back to reference Van Harmelen V, Ariapart P, Hoffstedt J, et al. Increased adipose angiotensinogen gene expression in human obesity. Obes Res. 2000;8:337–41.CrossRefPubMed Van Harmelen V, Ariapart P, Hoffstedt J, et al. Increased adipose angiotensinogen gene expression in human obesity. Obes Res. 2000;8:337–41.CrossRefPubMed
13.
go back to reference Korenkov M, Shah S, Sauerland S, et al. Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term. Obes Surg. 2007;17:679–83.CrossRefPubMed Korenkov M, Shah S, Sauerland S, et al. Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term. Obes Surg. 2007;17:679–83.CrossRefPubMed
14.
go back to reference Fanari P, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes Relat Metab Disord. 1993;17:487–94.PubMed Fanari P, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes Relat Metab Disord. 1993;17:487–94.PubMed
15.
go back to reference Freedman DS, Joesoef MR, Barboriak JJ, et al. Correlates of leukocyte counts in men. Ann Epidemiol. 1996;6:74–82.CrossRefPubMed Freedman DS, Joesoef MR, Barboriak JJ, et al. Correlates of leukocyte counts in men. Ann Epidemiol. 1996;6:74–82.CrossRefPubMed
16.
go back to reference Paolo F, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes. 1993;17:487–94. Paolo F, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes. 1993;17:487–94.
17.
go back to reference Marks HH. Influence of obesity on morbidity and mortality. Bull NY Acad Med. 1960;36:296–312. Marks HH. Influence of obesity on morbidity and mortality. Bull NY Acad Med. 1960;36:296–312.
18.
go back to reference Tracey VV, De NC, Harper JR. Obesity and respiratory infection in infants and young children. Br Med J. 1971;1:16–8.CrossRefPubMed Tracey VV, De NC, Harper JR. Obesity and respiratory infection in infants and young children. Br Med J. 1971;1:16–8.CrossRefPubMed
19.
go back to reference Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27:355–61.CrossRefPubMed Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27:355–61.CrossRefPubMed
20.
go back to reference Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002;26:659–62.CrossRefPubMed Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002;26:659–62.CrossRefPubMed
21.
go back to reference Vázquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22.CrossRefPubMed Vázquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22.CrossRefPubMed
22.
go back to reference Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042–7.CrossRefPubMed Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042–7.CrossRefPubMed
23.
go back to reference Marckmann P, Toubro S, Astrup A. Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr. 1998;52:329–33.CrossRefPubMed Marckmann P, Toubro S, Astrup A. Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr. 1998;52:329–33.CrossRefPubMed
24.
go back to reference Primrose JN, Davies JA, Prentice CR, et al. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68:396–9.PubMed Primrose JN, Davies JA, Prentice CR, et al. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68:396–9.PubMed
25.
go back to reference Rowan BO, Kuhl DA, Lee MD, et al. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162–6.CrossRefPubMed Rowan BO, Kuhl DA, Lee MD, et al. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162–6.CrossRefPubMed
26.
go back to reference Ditschuneit HH, Flechtner-Mors M, Adler G. Fibrinogen in obesity before and after weight reduction. Obes Res. 1995;3:43–8.PubMed Ditschuneit HH, Flechtner-Mors M, Adler G. Fibrinogen in obesity before and after weight reduction. Obes Res. 1995;3:43–8.PubMed
27.
go back to reference Haffner SM, Mykkänen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975–80.PubMed Haffner SM, Mykkänen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975–80.PubMed
28.
go back to reference Stallone DD, Stunkard AJ, Zweiman B, et al. Decline in delayed-type hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol. 1994;1:202–5.PubMed Stallone DD, Stunkard AJ, Zweiman B, et al. Decline in delayed-type hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol. 1994;1:202–5.PubMed
29.
go back to reference Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–60.PubMed Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–60.PubMed
30.
go back to reference Solá E, Jover A, López-Ruiz A, et al. Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg. 2009;19:571–6.CrossRefPubMed Solá E, Jover A, López-Ruiz A, et al. Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg. 2009;19:571–6.CrossRefPubMed
31.
go back to reference Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67:679–86.CrossRef Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67:679–86.CrossRef
32.
go back to reference Whitson BA, D'Cunha J, Hoang CD, et al. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Surg Obes Relat Dis. 2009;5:181–93.CrossRefPubMed Whitson BA, D'Cunha J, Hoang CD, et al. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Surg Obes Relat Dis. 2009;5:181–93.CrossRefPubMed
Metadata
Title
Comparison of Early and Late Changes in Immunoglobulins and Acute Phase Reactants after Laparoscopic Adjustable Gastric Banding in Patients with Morbid Obesity
Authors
İbrahim Sakçak
Mehmet Fatih Avşar
Enver Okan Hamamcı
Settar Bostanoğlu
Muhittin Sonışık
Akın Bostanoğlu
Nihal Zekiye Erdem
Erdal Coşgun
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 5/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-0061-y

Other articles of this Issue 5/2010

Obesity Surgery 5/2010 Go to the issue